Volume 18, Issue 5 pp. 586-587

Fixed drug eruption from piroxicam

E Cuerda Galindo

E Cuerda Galindo

Department of Dermatology, Hospital Juan Canalejo, C/Xubias de Arriba 84, 15006 A Coruña, Spain.

Search for more papers by this author
JJ Goday Buján

Corresponding Author

JJ Goday Buján

Department of Dermatology, Hospital Juan Canalejo, C/Xubias de Arriba 84, 15006 A Coruña, Spain.

* Corresponding author, tel. +34 981178000; E-mail: [email protected]Search for more papers by this author
JM García Silva

JM García Silva

Department of Dermatology, Hospital Juan Canalejo, C/Xubias de Arriba 84, 15006 A Coruña, Spain.

Search for more papers by this author
W Martínez

W Martínez

Department of Dermatology, Hospital Juan Canalejo, C/Xubias de Arriba 84, 15006 A Coruña, Spain.

Search for more papers by this author
M Verea Hernando

M Verea Hernando

Department of Dermatology, Hospital Juan Canalejo, C/Xubias de Arriba 84, 15006 A Coruña, Spain.

Search for more papers by this author
E Fonseca

E Fonseca

Department of Dermatology, Hospital Juan Canalejo, C/Xubias de Arriba 84, 15006 A Coruña, Spain.

Search for more papers by this author
First published: 02 July 2004
Citations: 10

ABSTRACT

The pathogenetic mechanism of fixed drug eruption (FDE) is still unknown. One of the most common causes of FDE is the use of nonsteroidal antiinflammatory drugs (NSAIDs). Oxicams are in the NSAID group and piroxicam is one of the most used of these drugs. FDE caused by piroxicam is rare but a few cases have been reported. Patch tests are useful for diagnosing some cases of FDE; they give variable results on previously affected skin while no reaction appears on unaffected skin. Some cases of cross-sensitivity among piroxicam and other substances have been reported. We report two new cases of FDE due to piroxicam with negative patch test on normal skin and positive results on affected skin.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.